These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2973086)

  • 1. Comparison of low dose nicotinamide versus benzamide, administered per os, as radiosensitizers in a C3H mammary carcinoma.
    Kjellen E; Pero RW; Nilsson P
    Radiother Oncol; 1988 Aug; 12(4):327-31. PubMed ID: 2973086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinamide as a radiosensitizer of a C3H mouse mammary adenocarcinoma.
    Jonsson GG; Kjellén E; Pero RW
    Radiother Oncol; 1984 Mar; 1(4):349-53. PubMed ID: 6239306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosensitizing effects of nicotinamide on a C3H mouse mammary adenocarcinoma. A study on per os drug administration.
    Kjellén E; Pero RW; Cameron R; Ranstam J
    Acta Radiol Oncol; 1986; 25(4-6):281-4. PubMed ID: 3030057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential tumor radiosensitization by analogs of nicotinamide and benzamide.
    Horsman MR; Brown DM; Lemmon MJ; Brown JM; Lee WW
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1307-10. PubMed ID: 2944859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosensitization by nicotinamide in tumors and normal tissues: the importance of tissue oxygenation status.
    Horsman MR; Hansen PV; Overgaard J
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1273-6. PubMed ID: 2523883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships for tumour radiosensitization by analogues of nicotinamide and benzamide.
    Brown JM; Lemmon MJ; Horsman MR; Lee WW
    Int J Radiat Biol; 1991 Mar; 59(3):739-48. PubMed ID: 1672362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A review.
    Horsman MR
    Acta Oncol; 1995; 34(5):571-87. PubMed ID: 7546822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitization effects of nicotinamide on malignant and normal mouse tissue.
    Jonsson GG; Kjellén E; Pero RW; Cameron R
    Cancer Res; 1985 Aug; 45(8):3609-14. PubMed ID: 2990674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor radiosensitization by nicotinamide: a result of improved perfusion and oxygenation.
    Horsman MR; Chaplin DJ; Brown JM
    Radiat Res; 1989 Apr; 118(1):139-50. PubMed ID: 2523079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hyperthermia and/or nicotinamide on the radiation response of a C3H mammary carcinoma.
    Kjellén E; Pero RW; Nilsson P; Hill SA
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1733-7. PubMed ID: 2534381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy.
    Rojas A; Hirst VK; Calvert AS; Johns H
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):357-65. PubMed ID: 8567336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour radiosensitization by nicotinamide: is it the result of an improvement in tumour oxygenation?
    Horsman MR; Nordsmark M; Khalil A; Chaplin DJ; Overgaard J
    Adv Exp Med Biol; 1994; 345():403-9. PubMed ID: 8079736
    [No Abstract]   [Full Text] [Related]  

  • 13. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
    Horsman MR; Overgaard J
    Radiother Oncol; 2004 Mar; 70(3):301-9. PubMed ID: 15064017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
    Dorie MJ; Menke D; Brown JM
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):145-50. PubMed ID: 8270435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of normobaric oxygen on tumor radiosensitivity: fractionated studies.
    Rojas A; Carl U; Reghebi K
    Int J Radiat Oncol Biol Phys; 1990 Mar; 18(3):547-53. PubMed ID: 2108105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and physiological changes induced by nicotinamide in a C3H mouse mammary carcinoma and CDF1 mice.
    Horsman MR; Kristjansen PE; Mizuno M; Christensen KL; Chaplin DJ; Quistorff B; Overgaard J
    Int J Radiat Oncol Biol Phys; 1992; 22(3):451-4. PubMed ID: 1531212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiosensitizing effect of nicotinamide and carbogen combined in fractionated pions or x-rays in SCCVII tumors.
    Ohizumi Y; Lam GK; Pickles T; Fryer C; Chaplin DJ
    Radiat Med; 1995; 13(6):291-5. PubMed ID: 8850370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of nicotinamide and carbogen breathing to improve tumour oxygenation prior to radiation treatment.
    Horsman MR; Siemann DW; Nordsmark M; Khalil AA; Overgaard J; Chaplin DJ
    Adv Exp Med Biol; 1994; 361():635-42. PubMed ID: 7597993
    [No Abstract]   [Full Text] [Related]  

  • 19. Tests of two electron-affinic radiosensitizers in vivo using regrowth of an experimental carcinoma.
    Denekamp J; Harris SR
    Radiat Res; 1975 Feb; 61(2):191-203. PubMed ID: 1110975
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential radiosensitization by the poly(ADP-ribose) transferase inhibitor 3-aminobenzamide in human tumor cells of varying radiosensitivity.
    Kelland LR; Burgess L; Steel GG
    Int J Radiat Oncol Biol Phys; 1988 Jun; 14(6):1239-46. PubMed ID: 3133329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.